Previous close | 357.38 |
Open | 357.05 |
Bid | 379.00 |
Ask | 387.60 |
Strike | 380.00 |
Expiry date | 2024-06-21 |
Day's range | 357.05 - 357.40 |
Contract range | N/A |
Volume | |
Open interest | 84 |
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.